Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Arch Biopartners Inc
V.ARCH
Alternate Symbol(s):
ACHFF
Technology
Scientific & Technical Instruments
Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is...
LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:ARCH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Nov 09, 2021 9:11pm
Arch Biopartners - My Due Diligence
Here is the science published by a world renounced third party: Dipeptidase-1 ( Metablok) mice, with survival increasing from 0% to 83%
...more
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Nov 09, 2021 4:59pm
Todays House Positions
House Positions for C:ARCH from 20211109 to 20211109 House Bought $Val Ave Sold $Val Ave
...more
(22)
•••
Bertie20
X
View Profile
View Bullboard History
Comment by
Bertie20
on Nov 09, 2021 4:20pm
RE:RE:Wall gone
Some amber nectar coming your way, Goldenarm
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Nov 09, 2021 4:06pm
$3.65 - Extremely Undervalued in Comparison to peers
The recent realization by the market has made the Arch chart look incredible, but lets no forget that we are extremely undervalued compared to our peer Current Market cap 182 mil US
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Nov 09, 2021 3:48pm
RE:Wall gone
Sellers, don't let the vapour tail hit you on the way out. To those who followed me from the other boards enjoy and you owe me a beer.
(6)
•••
Arbourmark
X
View Profile
View Bullboard History
Post by
Arbourmark
on Nov 09, 2021 3:20pm
Wall gone
Market maker house 22 took out the TD wall of 43,000 now clear sailing. We should see $4 this week!
(22)
•••
Bertie20
X
View Profile
View Bullboard History
Comment by
Bertie20
on Nov 09, 2021 3:13pm
RE:RE:RE:RE:RE:RE:Momentum continues
This is on a real tear--just passed $3.60. Bring on news of Phase 3!
(75)
•••
Antonius2
X
View Profile
View Bullboard History
Comment by
Antonius2
on Nov 09, 2021 2:19pm
RE:Manipulation
Good catch Arbourmark - that appear to be exactly what is happening.
(180)
•••
stocksarefun
X
View Profile
View Bullboard History
Comment by
stocksarefun
on Nov 09, 2021 2:18pm
RE:Manipulation
Spoke to the CEO about this, he doesn't believe there is any suspicious activity. I think it's a fairly standard accumulation strategy that is designed by very smart people to keep the
...more
(6)
•••
Arbourmark
X
View Profile
View Bullboard History
Post by
Arbourmark
on Nov 09, 2021 1:18pm
Manipulation
I would like to point out a pattern developing here if you do a level 2 search. Yesterday TD (house 7) placed a 43,000 ask wall up at $3.39 in late morning. At 3:59pm just 1 minute before the close
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Nov 09, 2021 11:09am
RE:RE:RE:RE:RE:Momentum continues
$3.50 and no one even knows who arch is yet!
(1)
•••
fourbarrels
X
View Profile
View Bullboard History
Comment by
fourbarrels
on Nov 08, 2021 7:01pm
RE:RE:RE:RE:Momentum continues
Love the optimism. I'll stay long.
(2)
•••
2019champs
X
View Profile
View Bullboard History
Comment by
2019champs
on Nov 08, 2021 6:15pm
RE:RE:RE:Momentum continues
$7 is roughly 350M market cap usd. Thats super cheap
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Nov 08, 2021 5:26pm
RE:RE:Momentum continues
"IF" Arch gets a Phase III than that would mean there was a signal, a signal for an unmet 20 billion a year market! By $7 you mean $37!!!
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income